All News
Filter News
Found 808,890 articles
-
Four Independent Studies of Voraxaze® Published at European Hematology Conference 2022
6/9/2022
The European Hematology Association Conference published four independent studies of Voraxaze® by various investigators for inclusion in its June 2022 EHA Hybrid Congress abstract book and for publication in HemaSphere, EHA’s peer-reviewed, open access journal.
-
Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care
6/9/2022
GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer – the most prevalent cancer in men and the third most prevalent cancer overalli.
-
IRLAB Strengthens Its Management Team by Appointing Richard Godfrey as New CEO and Nicholas Waters as Executive Vice President and Head of R&D
6/9/2022
IRLAB Therapeutics IRLAB announced that additional expertise is added to the company's management team to leverage opportunities arising from recent commercial and scientific successes.
-
Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
6/9/2022
Takeda announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic dengue cases, with no important safety risks identified, in the overall population including both seropositive and seronegative individuals through four and a half years after vaccination in the pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study trial.
-
SINOVAC Polio Vaccine Prequalified by WHO
6/9/2022
SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that it received the World Health Organization prequalification for its Poliomyelitis Vaccine on June 2, 2022.
-
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
6/9/2022
Pulse Biosciences, Inc., a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ technology, announced the closing of its rights offering and the final results thereof.
-
Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.
6/9/2022
In accordance with the press release published on 9 June 2022, Mentice AB, has entered into an agreement to acquire all assets relating to the software solution Ankyras from Galgo Medical S.L., which was conditional on the receipt of external financing.
-
Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.
6/9/2022
Mentice AB announces the intention to acquire all assets of the Ankyras software suite from Galgo Medical S.L. for an amount of EUR 1.80 million with a possible additional purchase amount of EUR 0.975 million, and with a total purchase consideration amounting to approximately EUR 2.775 million to be paid in cash.
-
Biolase Announces Inaugural Clinical Excellence Forum
6/9/2022
BIOLASE, Inc., the global leader in dental lasers is proud to host its first annual meeting of leading dental laser experts on June 10, 2022 and June 11, 2022 at the Avenue of the Arts in Costa Mesa, CA.
-
Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022
6/9/2022
Sciwind Biosciences Co., Ltd. announced that two abstracts have been accepted for poster presentations at The International Liver CongressTM 2022, the Annual Meeting of the European Association for the Studies of the Liver taking place June 22-26 in London, United Kingdom.
-
REGENXBIO Opens State-of-the-Art Gene Therapy Manufacturing Facility
6/9/2022
REGENXBIO Inc. is celebrating the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility.
-
Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene (OxBC)
6/9/2022
Avivagen Inc. is pleased to announce that it has completed a series of important safety evaluations of fully oxidized beta-carotene, the proprietary and critical active ingredient in the company’s highly-regarded OxC-beta™ product line.
-
NEXT Molecular Analytics Receives Accreditation from the New York State Department of Health for its L-Asparaginase Enzyme Activity Assay Platform
6/9/2022
NEXT Bio Research Services LLC, dba NEXT Molecular Analytics is pleased to announce that the New York State Department of Health has accredited the Company’s L-Asparaginase enzyme activity assay platform.
-
7 Hills Pharma Expands Pioneering Patent Portfolio With New Claims Covering Innovative Combination Therapies
6/9/2022
7 Hills Pharma LLC has secured newly issued US patent claims that significantly expand the extent of the company’s intellectual property estate.
-
BioInvent Appoints Sylvie Ryckebusch as Chief Business Officer
6/9/2022
BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer immunotherapy, announces the appointment of Sylvie Ryckebusch as Chief Business Officer.
-
Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS Patient
6/9/2022
Tiziana Life Sciences announces an interview with Chief Executive Officer and Chief Scientific Officer Kunwar Shailubhai, PhD and Proactive Investors discussing the positive clinical results from the second patient with Secondary Progressive Multiple Sclerosis in the ongoing study as part of an expanded access program at the Brigham and Women’s Hospital, Boston, MA.
-
Spectrum Chemical Enters into New Distribution Arrangement with ANGUS Chemical Company to Provide Select TRIS Buffers and Derivatives for Life Sciences and Biopharmaceuticals Markets in United States and Canada
6/9/2022
Spectrum Chemical Mfg. Corp. has entered into a new distribution arrangement with ANGUS Chemical Company that expands Spectrum Chemical’s product offerings for research and development and production scale-up at commercial and academic organizations serving the biopharmaceutical and life sciences industries in the United States and Canada.
-
Tiziana Life Sciences PLC (TLSA: NASDAQ) Clinical Improvements for 2nd SPMS Patient
6/9/2022
Tiziana Life Sciences PLC announced positive clinical results for its second secondary progressive multiple sclerosis patient in a June 8th press release.
-
Ocugen, Inc. to Present at BIO International Convention 2022
6/9/2022
Ocugen, Inc. announced that Michael Shine, Ocugen’s Senior Vice President, Commercial, will present at the 2022 BIO International Convention being held in San Diego, California, from June 13-16, 2022.
-
FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy
6/9/2022
bluebird bio, Inc. announced the outcome of the U.S. Food and Drug Administration’s Cellular, Tissue, and Gene Therapies Advisory Committee discussion of elivaldogene autotemcel for the treatment of early active cerebral adrenoleukodystrophy in patients less than 18 years of age who do not have an available and willing human leukocyte antigen -matched sibling hematopoietic stem cell donor.